Startup Spun Out of Nobel Laureate’s Lab Teams with Eli Lilly to Fight Cancer with AI

Lila Biologics, a startup from Nobel Laureate David Baker’s University of Washington lab, announced a collaboration with Eli Lilly to develop solid tumor therapies. The company also launched two AI-powered platforms: one for targeted radiotherapy that delivers radioactive isotopes directly to tumors, and another for creating long-acting injectable drugs designed to release medicine gradually over weeks or months.